Tacrolimus Elimination in Four Patients With a CYP3A5*3/*3 CYP3A4*22/*22 Genotype Combination.

Scheibner, Aileen; Remmel, Rory; Schladt, David; Oetting, William S; Guan, Weihua; Wu, Baolin; Dorr, Casey; Israni, Ajay; Jacobson, Pamala A

Scheibner, Aileen; Remmel, Rory; Schladt, David; Oetting, William S; Guan, Weihua; Wu, Baolin; Dorr, Casey; Israni, Ajay; Jacobson, Pamala A.

Afiliación

Scheibner A; University of Minnesota College of Pharmacy, Minneapolis, Minnesota.
Remmel R; Department of Medicinal Chemistry, University of Minnesota College of Pharmacy, Minneapolis, Minnesota.
Schladt D; Minneapolis Medical Research Foundation, Minneapolis, Minnesota.
Oetting WS; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota.
Guan W; Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota.
Wu B; Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota.
Dorr C; Division of Nephrology, Department of Medicine, Hennepin Country Medical Center, Minneapolis, Minnesota.
Israni A; Minneapolis Medical Research Foundation, Minneapolis, Minnesota.
Jacobson PA; Division of Nephrology, Department of Medicine, Hennepin Country Medical Center, Minneapolis, Minnesota.

Pharmacotherapy ; 38(7): e46-e52, 2018 Jul.

Article en En | MEDLINE | ID: mdl-29804290

Palabras clave

CYP3A4; CYP3A5; Transplant; kidney; pharmacogenetics; single nucleotide polymorphisms; tacrolimus

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Pharmacotherapy Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google